This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grasso, P. Articles by Reichert, L. E. Search for Related Content PubMed PubMed Citation Articles by Grasso, P. Articles by Reichert, L. E., Jr.

A Synthetic Peptide Corresponding to Amino Acid Residues 34 to 37 of Human Follicle-Stimulating Hormone ß-Subunit Accelerates the Onset of Puberty in Male and Female Mice¹

Department of Biochemistry and Molecular Biology, Albany Medical College, Albany, New York 12208

Address all correspondence and requests for reprints to: Dr. Leo E. Reichert, Jr., Department of Biochemistry and Molecular, Biology A-10, Albany Medical College, Albany, New York 12208.

We have previously reported that a synthetic peptide amide corresponding to residues 34–37 (TRDL, threonine, arginine-aspartic acid-leucine) of the ß-subunit of human FSH induced prolonged vaginal estrus in normally cycling female mice (see Ref. 15). These results represented the first demonstration of an in vivo effect of a gonadotropin-related synthetic peptide on reproductive processes. We have extended these studies to examine possible effects of TRDL on the onset of puberty in female mice. In two replicated experiments, vehicle-injected control mice attained first vaginal estrus by day 39. An ip injection of 200 ug TRDL/g BW to 28-day-old prepubertal female mice, however, accelerated the onset of first vaginal estrus by 7 days in 11 of 12 (11/12) (Exp 1) and 7/9 (Exp 2) mice. Serum estradiol levels were significantly (P = 0.017) elevated in TRDL-treated mice, whereas progesterone was unchanged. Uteri of TRDL-treated mice were significantly (P = 0.003) heavier than uteri of vehicle-injected control animals of the same age and body weight. Intraluminal fluid accumulation (ballooning) at proestrus was absent in 20/21 TRDL-treated females, as were oviductal ova and ovarian corpora lutea. These phenomena are characteristic of the first estrous cycles of female mice isolated from males. To obtain further evidence for in vivo effects of TRDL, we assessed the ability of TRDL to accelerate the onset of puberty in male mice. When given as five consecutive daily ip injections of 200 ug/g BW to 28-day-old prepubertal male mice, TRDL significantly increased testis weight, when compared with vehicle-injected control mice of the same age and BW (171.3 ± 3.8 mg vs. 151.6 ± 4.3 mg, P = 0.001) and induced a 6.5-fold increase in serum testosterone levels. These studies confirm the previously reported in vivo activity of a synthetic peptide corresponding to human FSH-ß subunit 34–37 (TRDL) in adult female mice and extend its effects to the acceleration of the onset of puberty in immature male and female mice.

This article has been cited by other articles:

				J. Y. Wu and A. R. Means Ca2+/Calmodulin-dependent Protein Kinase IV Is Expressed in Spermatids and Targeted to Chromatin and the Nuclear Matrix J. Biol. Chem., March 10, 2000; 275(11): 7994 - 7999. [Abstract] [Full Text] [PDF]